Trial Profile
A pilot interventional study to arrest the progression of cognitive decline in diabetic patients at high risk of developing Alzheimer's disease by reducing hypoglycemic events
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2018
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin detemir; Insulin glargine; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIABMIND
- 13 Jun 2018 New trial record